SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-027675
Filing Date
2024-06-11
Accepted
2024-06-11 16:13:02
Documents
1
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718136772.html 4  
1 FORM 4 wk-form4_1718136772.xml 4 3537
  Complete submission text file 0001628280-24-027675.txt   5136
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NOVELION THERAPEUTICS INC. 1800-510 WEST GEORGIA STREET VANCOUVER A1 V6B OM3
Business Address
Stewart Murray (Reporting) CIK: 0001723450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 241035902